TL;DR
Whole-body MRI (WBMRI) effectively detects peripheral enthesitis, a key feature of axial spondyloarthritis (axSpA), and its distribution can aid diagnosis. An enthesitis scoring system shows greater diagnostic utility than simply counting affected sites, offering a more refined tool for axSpA assessment.
What Problem Does This Paper Address?
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease affecting the axial skeleton, often leading to significant pain and disability. A major challenge in axSpA diagnosis is the delay, which can worsen patient outcomes. While current classification criteria exist, they sometimes rely on sacroiliitis visible on MRI, which can be atypical or even present in healthy individuals. Enthesitis, the inflammation of tendon and ligament insertions, is a hallmark of spondyloarthritis. However, current classification criteria only explicitly include heel enthesitis, leaving the diagnostic value of peripheral enthesitis at other sites underexplored. This paper aims to address this gap by investigating the distribution and diagnostic value of peripheral enthesitis detected by WBMRI in axSpA, and to evaluate the utility of a scoring system for this condition.
Methods
The study employed whole-body magnetic resonance imaging (WBMRI) to assess peripheral enthesitis. Sixty patients diagnosed with axSpA and 50 controls with chronic low back pain (LBP) underwent WBMRI. The WBMRI protocol included specific sequences (T1-weighted mDixon and STIR) to detect bone marrow edema (BME) and soft tissue inflammation at entheseal sites. A standardized scoring system was used, evaluating bone marrow edema (0-2) and soft tissue inflammation (0-2) at 18 specific locations across five regions (shoulder, anterior chest wall, pelvis, knee, and foot). A total of 47 entheseal sites were assessed per patient, with scores ranging from 0 to 188. Radiologists independently scored the images, blinded to clinical information. Statistical analyses included ROC curve analysis to determine diagnostic value, with AUC and Youden index used to identify optimal cutoff points.
Datasets
The study utilized a dataset of 60 patients diagnosed with axSpA (including ankylosing spondylitis and non-radiographic axSpA) and 50 control individuals with chronic low back pain. No new benchmark datasets were introduced.
Key Insights and Ideas
- WBMRI as a comprehensive tool: WBMRI proves to be an effective method for visualizing and assessing peripheral enthesitis across the entire body, offering a broader perspective than localized imaging.
- Pelvis as a key site: The pelvis emerged as the most frequently affected region for enthesitis in axSpA patients, highlighting its importance in the disease's peripheral manifestations.
- Anterior chest wall's high specificity: Enthesitis in the anterior chest wall demonstrated exceptionally high specificity, making it a valuable indicator when differentiating axSpA from other conditions.
- Osteitis vs. soft tissue inflammation: In axSpA patients, osteitis (bone marrow edema) was more prevalent than soft tissue inflammation, suggesting a distinct inflammatory pattern compared to controls.
- Scoring system's superiority: An enthesitis scoring system demonstrated better diagnostic efficacy than simply counting the number of affected entheseal sites, offering a more nuanced assessment.
- Enthesitis as an independent marker: The lack of correlation between enthesitis scores and clinical disease activity markers (like ASDAS, CRP, ESR) suggests that peripheral enthesitis might be an independent feature of axSpA, not solely reflective of current disease activity.
Key Results
- WBMRI identified enthesitis in 78.3% of axSpA patients (47 out of 60) and 32% of controls (16 out of 50).
- The pelvis was the most affected region in axSpA patients, accounting for 51.6% of involved patients.
- Anterior chest wall enthesitis showed 100% specificity for axSpA diagnosis.
- The AUC for the number of enthesitis sites was 0.819, and for the enthesitis score was 0.833, both indicating significant diagnostic value.
- A cutoff of three enthesitis sites or an enthesitis score of 3 showed high specificity (98%) for axSpA diagnosis, with sensitivities of 53.33% and 58.33%, respectively.
- The enthesitis score showed better diagnostic efficiency than the number of enthesitis sites.
Limitations and Future Work
The authors acknowledge several limitations:
- Real-world study design: The study included patients with diverse disease courses and treatments, which may introduce variability.
- Control group limitations: No clinical diagnosis of enthesitis was made in the control group, and the scanning strategy could be improved.
- Selection bias: WBMRI is not a routine examination, leading to a potential selection bias where the prevalence of axSpA in LBP patients might be higher than in the general population.
- Need for further validation: Follow-up studies with larger sample sizes are needed to confirm the findings.
Future work could focus on exploring the distribution and outcomes of enthesitis in relation to different disease courses and treatments. Further research is also needed to refine WBMRI scanning techniques and improve image quality, especially for joints at the periphery of the field of view. Investigating the role of contrast-agent use in improving MRI sensitivity and specificity for enthesitis is also suggested.
Summary updated